📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Hemerus

1.1 - Company Overview

Hemerus Logo

Hemerus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of technologies for the collection, processing, preservation and storage of blood and blood products, including the SOLX System for whole blood collection and leukoreduction with preparation of red blood cells and plasma from blood held at room temperature for up to 24 hours; LEUP leukoreduction processing circuits enabling single-step, ventless processing; and LEUKOSEP leukocyte reduction filters with minimal residual hold-up.

Products and services

  • LEUKOSEP™ Leukocyte Reduction Filter: An industrial-grade filter engineered to remove leukocytes from blood products, delivering efficient leukoreduction with minimal residual hold-up
  • LEUP™ Leukoreduction Processing Circuits: A ventless, single-step processing circuit that enables leukoreduction of blood products, improving efficiency and freeing up operator time
  • SOLX™ System: A room-temperature system for collection and leukoreduction of whole blood, preparing red blood cells and plasma from blood held for up to 24 hours

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Hemerus

Veralox Therapeutics Logo

Veralox Therapeutics

HQ: United States Website
  • Description: Provider of small molecule therapeutics targeting the 12-LOX pathway for thrombosis and Type 1 Diabetes. Products include VLX-1005, a first-in-class drug for treating Heparin-Induced Thrombocytopenia by inhibiting platelet activation through 12-LOX pathway inhibition; VLX-2000 Series under development to protect β cells and improve insulin production; plus an Expanded Access Program for investigational medicines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Veralox Therapeutics company profile →
Hemcheck Logo

Hemcheck

HQ: Sweden Website
  • Description: Provider of point-of-sampling products that identify non-analyzed blood samples by detecting hemolysis (broken red blood cells), the most common cause of sample non-analysis. Helge detects hemolysed blood samples, addressing issues that lead to poorer care, patient risk, and high societal costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hemcheck company profile →
ExThera Medical Logo

ExThera Medical

HQ: United States Website
  • Description: Provider of hemoperfusion and extracorporeal blood filtration devices, including Seraph 100 for treating severe COVID-19 by removing pathogens from the bloodstream and ONCOBind for adsorbing circulating tumor cells from plasma in metastatic cancer patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ExThera Medical company profile →
SynGen Logo

SynGen

HQ: United States Website
  • Description: Provider of advanced cell separation tools and accessories for regenerative medicine workflows, inventing and commercializing single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood and bone marrow.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SynGen company profile →
CytoPherx Logo

CytoPherx

HQ: United States Website
  • Description: Provider of a proprietary selective cytopheresis system for inflammation-based diseases and conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoPherx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Hemerus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Hemerus

2.2 - Growth funds investing in similar companies to Hemerus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Hemerus

4.2 - Public trading comparable groups for Hemerus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Hemerus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Hemerus

What does Hemerus do?

Hemerus is a provider of technologies for the collection, processing, preservation and storage of blood and blood products, including the SOLX System for whole blood collection and leukoreduction with preparation of red blood cells and plasma from blood held at room temperature for up to 24 hours; LEUP leukoreduction processing circuits enabling single-step, ventless processing; and LEUKOSEP leukocyte reduction filters with minimal residual hold-up.

Who are Hemerus's competitors?

Hemerus's competitors and similar companies include Veralox Therapeutics, Hemcheck, ExThera Medical, SynGen, and CytoPherx.

Where is Hemerus headquartered?

Hemerus is headquartered in United States.

How many employees does Hemerus have?

Hemerus has 1,000 employees 🔒.

When was Hemerus founded?

Hemerus was founded in 2010 🔒.

What sector and industry vertical is Hemerus in?

Hemerus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Hemerus

Who are the top strategic acquirers in Hemerus's sector and industry

Top strategic M&A buyers and acquirers in Hemerus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Hemerus?

Top strategic M&A buyers groups and sectors for Hemerus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Hemerus's sector and industry vertical

Which are the top PE firms investing in Hemerus's sector and industry vertical?

Top PE firms investing in Hemerus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Hemerus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Hemerus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Hemerus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Hemerus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Hemerus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Hemerus?

The key public trading comparables and valuation benchmarks for Hemerus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Hemerus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Hemerus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Hemerus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Hemerus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Hemerus's' sector and industry vertical?

Access recent funding rounds and capital raises in Hemerus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Hemerus